Management of Small Vessel Ischemic Changes

Primary Prevention and Treatment

The American Heart Association recommends antiplatelet agents, such as aspirin, for older adults with small vessel ischemic changes and vascular risk factors, as they offer a proven benefit in reducing the risk of further ischemic events 1, 2
The American College of Cardiology recommends aspirin 50-325 mg daily as a Class I, Level A recommendation for secondary prevention in noncardioembolic ischemic stroke, which includes small vessel disease 2
The combination of aspirin plus extended-release dipyridamole is preferred over aspirin alone, offering superior stroke prevention, according to the American Stroke Association (Class I, Level B) 2
Clopidogrel 75 mg daily may be considered instead of aspirin alone, though the evidence is less robust than for aspirin-dipyridamole combination, as stated by the American Heart Association (Class IIb, Level B) 2

The American Heart Association emphasizes that blood pressure control is the single most important intervention for small vessel disease, with a target blood pressure of <130/80 mm Hg for secondary stroke prevention (Class IIb recommendation) 4, 5
High-dose statin therapy, such as atorvastatin 80 mg daily, provides stroke protection even in patients with normal cholesterol levels, according to the American College of Cardiology 6, 5
Target LDL-C <100 mg/dL (or <70 mg/dL for very high-risk patients) is recommended by the American Heart Association 7, 6

If atrial fibrillation is present, the American College of Chest Physicians recommends using oral anticoagulation, such as dabigatran 150 mg bid, as the preferred treatment (Grade 2B) 1, 3
If no atrial fibrillation is present, the American Stroke Association recommends proceeding to antiplatelet therapy, with aspirin 75-162 mg + extended-release dipyridamole as the first choice (Class I, Level B) 1, 2

Antiplatelet therapy, such as aspirin-based regimens, is recommended for protection against further ischemic events in small vessel disease, according to the American Heart Association 1, 2
Aggressive blood pressure control, with a target blood pressure of <130/80 mm Hg, is essential for reducing the risk of further ischemic events, as stated by the American Heart Association 4, 5
High-dose statin therapy, such as atorvastatin 80 mg, is recommended for stroke protection, according to the American College of Cardiology 6, 5